Comprehensive Choices for Oncology Care Available from BioPlus

Share Article

BioPlus Specialty Pharmacy, one of the nation’s leading specialty pharmacies, offers numerous oncology drugs as well as an oncology therapy management program that increases patient compliance.

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading specialty pharmacies, has numerous oral oncology medications available for patients with cancer. As a specialty pharmacy, BioPlus works with patients and their physicians in oncology treatments requiring the use of complex oncology therapies, including:

  •     Revlimid
  •     Thalomid
  •     Temodar
  •     Sutent
  •     Nexavar
  •     Sprycel
  •     Tarceva
  •     Xeloda
  •     Gleevec
  •     Tasigna

BioPlus offers a thorough program to help patients with cancer manage their oncology treatment. “This program makes it as easy as possible for patients to start their therapy, while also helping prescribers and patients reach the best possible outcomes,” says Dr. Stephen Vogt, president and CEO of BioPlus.

BioPlus relies on an experienced oncology team, expedited prescription service, and a knowledgeable clinical team to reach this goal. The services offered by BioPlus as part of this overall oncology therapy management program are performed monthly for each patient and include:

  •     Side effect management
  •     Monthly patient counseling
  •     Product education
  •     Therapy education
  •     Therapy adherence monitoring
  •     Therapy outcomes communicated to the physician
  •     Treatment intervention

Nexavar, a complex oncology medication provided by BioPlus, treats a type of kidney cancer called advanced renal cell carcinoma. “By following the oncology therapy management program for each patient, BioPlus has been able to achieve average refill rates of six to eight per patient for Nexavar,” Dr. Vogt points out. This indicator of high patient compliance demonstrates the successfulness of the oncology management treatment program, which plays a significant role for patients achieving the best possible treatment outcomes.

Revlimid, another complex oncology medication, is an oral medication approved for the treatment of two indications: myelodysplastic syndrome and multiple myeloma. Myelodysplastic syndrome is a group of conditions in which the bone marrow produces misshapen blood cells. Multiple myeloma is a cancer affecting the bone marrow. Revlimid, an immunomodulatory agent, helps the bone marrow produce normal blood cells and kills abnormal cells in the bone marrow.

Oncology therapies are complex and each medication comes with its own set of benefits and challenges. For example, with the medication Revlimid, Dr. Vogt notes that “as our excellent track record with other complex oral chemotherapy agents demonstrates, the added touch of patient education, encouragement, and evaluation to plan will show the value of using BioPlus in efficient starts of therapy and above-average national refill rates.”

About BioPlus Specialty Pharmacy

Florida-based BioPlus is a pharmacist-owned national specialty infusion pharmacy company designed to provide high-touch services and specialty pharmaceuticals for patients with chronic diseases such as arthritis, hepatitis C, cancer, and others. Licensed in all 50 states, BioPlus is one of the nation’s largest independent specialty pharmacies. Accredited by the Community Health Accreditation Program (CHAP), patients can contact the Pharmacy toll free at 1-888-292-0744.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Denise Houston

Sharon Ferrer
Visit website